Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

What we know and what we should know on immunotherapy and endometrial cancer (EC)

Overcoming the resistance to IO: What can we do?

Date

15 Sep 2024

Session

What we know and what we should know on immunotherapy and endometrial cancer (EC)

Topics

Tumour Site

Endometrial Cancer

Presenters

Frederik Marmé

Authors

F. Marmé

Author affiliations

  • Gynecologic Oncology Department, UMM - Universitaetsklinikum Mannheim - Medizinische Fakultaet, 68167 - Mannheim/DE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Session: What we know and what we should know on immunotherapy and endometrial cancer (EC)

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.